NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 02 04:00PM ET
10.24
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)- Insider Own21.26% Shs Outstand17.25M Perf Week-0.19%
Market Cap224.36M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float17.25M Perf Month0.69%
Enterprise Value224.15M PEG- EPS next Q- Inst Own55.74% Short Float0.01% Perf Quarter2.20%
Income- P/S- EPS this Y- Inst Trans- Short Ratio0.02 Perf Half Y-
Sales- P/B1.32 EPS next Y- ROA- Short Interest0.00M Perf YTD2.30%
Book/sh7.77 P/C1068.37 EPS next 5Y- ROE- 52W High10.30 -0.58% Perf Year-
Cash/sh0.01 P/FCF- EPS past 3/5Y-13.14% - ROIC- 52W Low10.00 2.40% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.04% 0.09% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.02 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.29 Sales Y/Y TTM- Profit Margin- RSI (14)59.42 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.29 EPS Q/Q- SMA200.26% Beta- Target Price-
Payout- Debt/Eq0.00 Sales Q/Q- SMA500.94% Rel Volume0.00 Prev Close10.24
Employees2 LT Debt/Eq0.00 Earnings- SMA2001.27% Avg Volume54.49K Price10.24
IPOFeb 13, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume0 Change0.00%
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.